Samsung Bioepis Denies Organon Deal Rumors

As Korean Biosimilars Player Makes Moves In Europe And Japan

 
• By Dave Wallace
  
Samsung Bioepis has denied rumors over a potential Organon deal (Shutterstock)

More from Deals

More from Business